Skip to content

Presentations and Outcomes of Acute Pancreatitis

Clinical Presentations and Outcomes in Patients With Acute Pancreatitis at Al-Rajhi University Hospital-Prospective Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07753980
Enrollment
100
Registered
2026-08-10
Start date
2026-09-01
Completion date
2027-10-01
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Pancreatitis

Keywords

acute pancreatitis, Al-Rajhi University Hospital

Brief summary

Evaluate the outcomes of the patients and their possible predictors.

Detailed description

Acute pancreatitis (AP) is an acute inflammatory disease of the pancreas characterized by variable involvement of regional tissues and distant organ systems. The disease may range from mild interstitial edema to severe pancreatic necrosis associated with multiple organ failure and high mortality rates \[1,2\]. Acute pancreatitis is considered one of the leading gastrointestinal causes of hospital admission worldwide and its incidence has progressively increased over recent decades \[3\]. The pathogenesis of acute pancreatitis is mainly related to premature activation of pancreatic digestive enzymes within pancreatic acinar cells, resulting in autodigestion of pancreatic tissue and activation of inflammatory pathways \[1\]. This inflammatory response may progress to systemic inflammatory response syndrome (SIRS), acute respiratory distress syndrome (ARDS), renal failure, shock, and multiorgan dysfunction syndrome (MODS) in severe cases\[ 2,4\]. Although approximately 80% of patients experience mild self-limited disease with favorable outcomes, nearly 20% develop severe acute pancreatitis associated with pancreatic necrosis, infected collections, persistent organ failure, and systemic complications \[3,8\]. The overall mortality rate of acute pancreatitis ranges from 3% to 10%, while mortality in severe acute pancreatitis may reach 20-30%, particularly in patients with infected pancreatic necrosis and persistent organ failure4 and \[8\].Early identification of severe disease and accurate assessment of prognosis are therefore essential to improve patient outcomes and reduce morbidity and mortality \[7,8\]. In Upper Egypt, particularly at Al-Rajhi University Hospital, prospective data regarding the clinical presentation, etiological factors, disease severity, complications, and outcomes of patients admitted with acute pancreatitis remain limited. In addition, the association between demographic characteristics, comorbidities, severity scores, and short-term clinical outcomes has not been adequately evaluated in the local population. Accordingly, this prospective study aims to describe the clinical characteristics of hospitalized patients with acute pancreatitis, identify factors associated with adverse outcomes, and evaluate the prognostic value of the Ranson and APACHE II scoring systems. The findings may contribute to improved early risk stratification, support clinical decision-making, optimize resource utilization, and ultimately enhance patient care at Al-Rajhi University Hospital.

Interventions

OTHERUS,MSCT abdomen,arterial blood gases

arterial blood gases

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\. Adult patients aged 18 years or older. 2. Patients fulfilling at least two diagnostic criteria of acute pancreatitis. 3. Patients willing to participate in the study.

Exclusion criteria

1. Patients with chronic pancreatitis. 2. Patients diagnosed with pancreatic malignancy. 3. Patients less than 18 years old. 4. Patients with incomplete clinical data. 5. Refusal to participate. -

Design outcomes

Primary

MeasureTime frame
Frequency and types of clinical patterns of acute pancreatitis and the fates of patients.july 2026-july 2027

Contacts

CONTACTRoaa M Khaled Hasanin, Resident doctor
ro2a5aled12@gmail.com00201008753743
CONTACTMadiha M El attar, professor
Melattarmakhlouf@aun.edu.eg00201005207841
STUDY_DIRECTORRasha H shehata, assistant professor

Assiut University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026